SEC Filing Summary: AspenBio Pharma, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by AspenBio Pharma, Inc. on May 17, 2007. The registrant is incorporated in Colorado with its principal executive offices in Castle Rock, CO. The filing serves to disclose the issuance of a press release regarding the company's results of operations and financial condition.
Note: The request metadata references "Riot Platforms, Inc.", but the provided filing text explicitly identifies the registrant as "AspenBio Pharma, Inc." This summary reflects the content of the provided text.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that a press release containing these details was issued on May 17, 2007, and is attached as Exhibit 99.1, but the text of the press release itself is not included in the provided input.
Material Changes
The filing references Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure), indicating that material information regarding the company's financial status was disclosed. However, the specific nature or magnitude of changes versus prior periods is not detailed in the provided text.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, forward-looking guidance, risk factors, or descriptions of unusual items. It solely confirms the public release of information via a press release.
Investor Verification Checklist
- Verify the content of the press release dated May 17, 2007, referenced as Exhibit 99.1, to obtain actual financial figures.
- Confirm the discrepancy between the request metadata (Riot Platforms, Inc.) and the filing registrant (AspenBio Pharma, Inc.).
- Review the full text of the press release for specific details on operational results and financial condition not present in this 8-K cover sheet.